Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1997-11-24
1999-06-29
Pak, John
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
514114, 514119, 514506, 514517, 514538, 514539, 514541, 514561, 514562, 514567, 514576, 514618, 514621, 514622, 558 49, 558 50, 558 60, 558169, 558170, 558174, 560 9, 560 36, 560 37, 560 42, 562 15, 562 42, 562426, 562441, 562442, 562451, 562455, 562456, 564162, 564169, 564171, A61K 31165, A61K 31055, A61K 3119, A61K 31255, C07C22900, C07C30924, C07C23300, C07F 938
Patent
active
059169222
ABSTRACT:
A class of novel phenyl glyoxamides is disclosed together with the use of such compounds for inhibiting sPLA.sub.2 mediated release of fatty acids for treatment of conditions such as septic shock.
REFERENCES:
patent: 4161491 (1979-07-01), Kleemann et al.
patent: 4224226 (1980-09-01), Kleemann et al.
patent: 4228082 (1980-10-01), Kleemann et al.
patent: 5344843 (1994-09-01), Guthrie et al.
patent: 5352690 (1994-10-01), Sofia
Geffken, D. et al., "An Improved Synthesis of N-Alkoxy-.alpha.-oxo-Arylacetamides", Synthetic Communications, vol. 26(22), pp. 4153-4156, 1996.
Ozawa, F. et al., "Palladium-Catalyzed Double Carbonylation of Aryl Halides to give .alpha.-Keto Amides. Mechanical Studies." J. Am. Chem. Soc., vol. 107, pp. 3235-3245, 1985.
Chemical Abstracts 113:114766m, 1990.
Chemical Abstracts 122:239485, 1995.
Goodson Jr. Theodore
Harper Richard Waltz
Herron David Kent
Eli Lilly and Company
Pak John
Palmberg Arleen
LandOfFree
Phenyl glyoxamides as SPLA2 inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Phenyl glyoxamides as SPLA2 inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phenyl glyoxamides as SPLA2 inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1375725